IQVIA Holdings | IQV - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Accenture USD 20.96B 1.06B 2025-12
Agilent USD 2.27B 35M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Cardinal Health USD 41.99B 1.33B 2026-03
Celltrion KRW 283.62B 3.72T 2025-12
Charles River Laboratories USD 1.09B 26.61M 2026-03
Cigna USD 52.61B 3.74B 2026-03
Cognizant Technology Solutions USD 3.52B 139M 2026-03
Computer Programs Systems USD 57.96M 4.21M 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
CVS Health USD 86.41B 2.29B 2026-03
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.21B 136M 2026-03
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Elevance Health USD 45.31B 4.27B 2026-03
Humana USD 21.51B 5.16B 2026-03
IBM USD 40.1B 1.44B 2026-03
Illumina USD 1.57B 19M 2026-03
Infosys INR 499.34B 35.36B 2025-12
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Laboratory Of America USD 2.64B 182.5M 2026-03
Malin Corporation EUR 1000K 500K 2024-12
McKesson USD 67.02B 1.11B 2026-03
Mettler Toledo International USD 1.11B 89.76M 2026-03
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pharma Mar EUR 89.23M 4.65M 2026-03
Publicis EUR 23.89B 3.02B 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Quest Diagnostics USD 2.18B 101M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Tilray USD 259.32M 8.32M 2025-09
UnitedHealth USD 114.12B 773M 2026-03
Veeva Systems USD 1.7B 64.71M 2026-03
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 1.24B 11.8M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03